<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">nnp</journal-id><journal-title-group><journal-title xml:lang="en">Neurology, Neuropsychiatry, Psychosomatics</journal-title><trans-title-group xml:lang="ru"><trans-title>Неврология, нейропсихиатрия, психосоматика</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-2711</issn><issn pub-type="epub">2310-1342</issn><publisher><publisher-name>"IMA-Press", LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/2074-2711-2019-2-30-36</article-id><article-id custom-type="elpub" pub-id-type="custom">nnp-1096</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL INVESTIGATIONS</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ И МЕТОДИКИ</subject></subj-group></article-categories><title-group><article-title>Susceptibility-weighted MR imaging (SWI) of basal ganglia iron deposition in the early and advanced stages of Parkinson's disease</article-title><trans-title-group xml:lang="ru"><trans-title>Визуализация железа по данным МР-изображений, взвешенных по неоднородности магнитного поля (SWI), в базальных ганглиях на ранних и развернутых стадиях болезни Паркинсона</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Труфанов</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Trufanov</surname><given-names>A. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Артем Геннадьевич Труфанов</p><p>194044, Санкт-Петербург, Выборгский район, Лесной проспект, 2  </p></bio><bio xml:lang="en"><p>Artem Gennadevich Trufanov</p><p>2, Lesnoy Prospect, Vyborsky District, Saint Petersburg 194044 </p></bio><email xlink:type="simple">trufanovart@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Юрин</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Yurin</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>194044, Санкт-Петербург, Выборгский район, Лесной проспект, 2  </p></bio><bio xml:lang="en"><p>2, Lesnoy Prospect, Vyborsky District, Saint Petersburg 194044 </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Буряк</surname><given-names>А. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Buriak</surname><given-names>A. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>194044, Санкт-Петербург, Выборгский район, Лесной проспект, 2  </p></bio><bio xml:lang="en"><p>2, Lesnoy Prospect, Vyborsky District, Saint Petersburg 194044 </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сандалов</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Sandalov</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>194044, Санкт-Петербург, Выборгский район, Лесной проспект, 2  </p></bio><bio xml:lang="en"><p>2, Lesnoy Prospect, Vyborsky District, Saint Petersburg 194044 </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Одинак</surname><given-names>М. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Odinak</surname><given-names>M. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>194044, Санкт-Петербург, Выборгский район, Лесной проспект, 2  </p></bio><bio xml:lang="en"><p>2, Lesnoy Prospect, Vyborsky District, Saint Petersburg 194044 </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Литвиненко</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Litvinenko</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>194044, Санкт-Петербург, Выборгский район, Лесной проспект, 2  </p></bio><bio xml:lang="en"><p>2, Lesnoy Prospect, Vyborsky District, Saint Petersburg 194044 </p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Военно-медицинская академия им. С.М. Кирова» Минобороны России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>S.M. Kirov Military Medical Academy, Ministry of Defense of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>14</day><month>06</month><year>2019</year></pub-date><volume>11</volume><issue>2</issue><fpage>30</fpage><lpage>36</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Trufanov A.G., Yurin A.A., Buriak A.B., Sandalov S.A., Odinak M.M., Litvinenko I.V., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Труфанов А.Г., Юрин А.А., Буряк А.Б., Сандалов С.А., Одинак М.М., Литвиненко И.В.</copyright-holder><copyright-holder xml:lang="en">Trufanov A.G., Yurin A.A., Buriak A.B., Sandalov S.A., Odinak M.M., Litvinenko I.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://nnp.ima-press.net/nnp/article/view/1096">https://nnp.ima-press.net/nnp/article/view/1096</self-uri><abstract><p>Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease and the first one among the nosological entities of parkinsonism. Susceptibility-weighted imaging (SWI), magnetic resonance imaging (MRI) pulse sequence, which allows the in vivo estimation of the values of iron deposition in different areas of the brain, is a potential technique for the early diagnosis of PD and for the study of the pathogenesis of its complications.</p><sec><title>Objective</title><p>Objective: to compare the values of iron deposition in the basal ganglia in Stages II and III PD and to determine the relationship of clinical findings to the level of iron deposition according to the SWI findings.</p></sec><sec><title>Patients and methods</title><p>Patients and methods. Twenty-four patients with Hoehn and Yahr Stages II (n=24) and III (n=12) PD were examined. All the patients underwent brain MRI on a Siemens TrioTim (3T) MRI scanner by using pulse sequences T1, T2, SWI and subsequently quantifying the iron deposition (SPIN software). The accumulation of iron is visualized as an area of reduced signal intensity on SWI, and its estimation in accordance with the SPIN program has accordingly a smaller value. The regions of interest on both sides were the dentate nucleus, substantia nigra, red nucleus, putamen, globus pallidus, and head of the caudate nucleus. The examination protocol also included tests using the following scales: the Unified Parkinson's Disease Rating Scale (UPDRS), the Mini-Mental State Examination (MMSE), Frontal Assessment Batter (FAB), Freezing of Gait (FOG), Gait and Balance Scale (GABS), the Epworth Daytime Sleepiness Scale, the Parkinson's Disease Quality of Life Questionnaire (PDQ), the Beck Depression Inventory, and the Clock-Drawing Test.</p></sec><sec><title>Results and discussion</title><p>Results and discussion. The investigators found significant (p&lt;0.05) correlations between the clinical picture and the level of iron deposition in the regions of interest in patients with Stage II PD: FOG – left caudate nucleus (r=-0.94); GABS – left caudate nucleus (r=-0.94); and in patients with stage III of the disease: UPDRS (full) – left red nucleus (r=-0.82), right globus pallidus (r=-0,80), left putamen (r=-0,96); UPDRS (Section 2) – left red nucleus (r=-0.77), left globus pallidus (r=-0.84); UPDRS (Section 3) – right putamen (r=-0,85), right globus pallidus (r=-0.78), left globus pallidus (r=-0,92); FOG – left globus pallidus (r=-0.81); GABS – left red nucleus (r=-0.96), left putamen (r=0.82), right putamen (r=-0.89), left globus pallidus (r=-0.82), right globus pallidus (r=-0.85), left caudate nucleus (r=-0.82), right caudate nucleus (r=-0.89); Beck Depression Inventory – right substantia nigra (r=-0.82).</p></sec><sec><title>Conclusion</title><p>Conclusion. SWI measurement of the values of iron deposition in the structures of the extrapyramidal system in PD provides an additional insight into the pathological processes occurring in them.</p></sec></abstract><trans-abstract xml:lang="ru"><p>Болезнь Паркинсона (БП) – второе по частоте нейродегенеративное заболевание после болезни Альцгеймера и первое среди нозологических форм паркинсонизма. SWI (Susceptibility-weighted imaging), импульсная последовательность магнитно-резонансной томографии (МРТ), позволяющая in vivo оценивать степень депонирования железа в различных областях головного мозга, является потенциальной методикой ранней диагностики БП и изучения патогенеза ее осложнений.</p><p>Цель исследования – сравнение степени отложения железа в базальных ганглиях у пациентов со II и III стадиями БП и определение связи клинических показателей с выраженностью депонирования железа по данным SWI.</p><sec><title>Пациенты и методы</title><p>Пациенты и методы. Обследовано 24 пациента с БП II (n=12) и III (n=12) стадий по Хен–Яру. Всем больным выполняли МРТ головного мозга на МР-томографе Siemens TrioTim (3Т) с применением импульсных последовательностей T1, T2, SWI и дальнейшей количественной оценкой депонирования железа (SPIN software). Накопление железа визуализируется как участок сниженной интенсивности сигнала на SWI, а его оценка с применением программы SPIN, соответственно, имеет меньшее количественное значение. Областями интереса с обеих сторон являлись: зубчатое ядро мозжечка, черная субстанция, красное ядро, скорлупа, бледный шар, головка хвостатого ядра. Также в протокол обследования входили: тестирование по шкалам UPDRS (United Parkinson,s Disease Rating Scale, UPDRS), MMSE (Mini-Mental State Examination), FAB (Frontal Assessment Battery), FOG (Freezing of Gait), GABS (Gait and Balance Scale), дневной сонливости Эпворта, оценки качества жизни при БП, депрессии Бека и тест рисования часов.</p></sec><sec><title>Результаты и обсуждение</title><p>Результаты и обсуждение. Были обнаружены следующие значимые (p&lt;0,05) корреляции между клинической картиной и степенью депонирования железа в исследованных областях у пациентов со II стадией БП: FOG – левое хвостатое ядро (r=-0,94); GABS – левое хвостатое ядро (r=-0,94); у больных с III стадией заболевания: UPDRS (full) – левое красное ядро (r=-0,82), правый бледный шар (r=-0,80), левая скорлупа (r=-0,96); UPDRS (2-й раздел) – левое красное ядро (r=-0,77), левый бледный шар (r=-0,84); UPDRS (3-й раздел) – правая скорлупа (r=-0,85), правый бледный шар (r=-0,78), левый бледный шар (r=-0,92); FOG – левый бледный шар (r=-0,81); GABS – левое красное ядро (r=-0,96), левая скорлупа (r=-0,82), правая скорлупа (r=-0,89), левый бледный шар (r=-0,82), правый бледный шар (r=-0,85), левое хвостатое ядро (r=-0,82), правое хвостатое ядро (r=-0,89); шкала депрессии Бека – правая черная субстанция (r=-0,82).</p></sec><sec><title>Заключение</title><p>Заключение. Количественное измерение степени депонирования железа по данным SWI МРТ в структурах экстрапирамидной системы при БП позволяет получить дополнительное представление о происходящих в них патологических процессах.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>Болезнь Паркинсона</kwd><kwd>изображения</kwd><kwd>взвешенные по магнитной восприимчивости</kwd><kwd>депонирование железа</kwd><kwd>биомаркер</kwd><kwd>магнитно-резонансная томография</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Parkinson's disease</kwd><kwd>susceptibility-weighted images</kwd><kwd>iron deposition</kwd><kwd>biomarker</kwd><kwd>magnetic resonance imaging</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Левин ОС, Федорова НВ. Болезнь Паркинсона. Москва: МЕДпресс-информ; 2015. 384 c.</mixed-citation><mixed-citation xml:lang="en">Levin OS, Fedorova NV. Bolezn' Parkinsona [Parkinson's disease]. Moscow: MEDpress-inform; 2015. 384 p.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Tanner CM, Goldman SM. Epidemiology of Parkinson's disease. Neurol Clin. 1996 May; 14(2):317-35.</mixed-citation><mixed-citation xml:lang="en">Tanner CM, Goldman SM. Epidemiology of Parkinson's disease. Neurol Clin. 1996 May; 14(2):317-35.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Kanasi E, Ayilavarapu S, Jones J. The aging population: demographics and the biology of aging. Periodontol 2000. 2016 Oct;72(1):13-8. doi: 10.1111/prd.12126.</mixed-citation><mixed-citation xml:lang="en">Kanasi E, Ayilavarapu S, Jones J. The aging population: demographics and the biology of aging. Periodontol 2000. 2016 Oct;72(1):13-8. doi: 10.1111/prd.12126.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Литвиненко ИВ, Одинак ММ, Труфанов АГ. Болезнь Паркинсона и синдромы паркинсонизма (Учебное пособие). Санкт-Петербург: ЭЛБИ-СПб; 2012. 75 c.</mixed-citation><mixed-citation xml:lang="en">Litvinenko IV, Odinak MM, Trufanov AG. Bolezn' Parkinsona i sindromy parkinsonizma (Uchebnoe posobie) [Parkinson's disease and parkinsonism syndromes (Textbook)]. SaintPetersburg: ELBI-SPb; 2012. 75 p.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Таппахов АА, Попова ТЕ, Николаева ТЯ и др. Генетическая основа болезни Паркинсона. Неврология, нейропсихиатрия, психосоматика. 2017;9(1):96-100. doi: 10.14412/2074-27112017-1-96-100</mixed-citation><mixed-citation xml:lang="en">Tappakhov AA, Popova TE, Nikolaeva TYa, et al. The genetic basis of Parkinson's disease. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2017;9(1): 96-100. (In Russ.). doi: 10.14412/2074-27112017-1-96-100</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Рыбкина ВЛ, Азизова ТВ. Факторы риска развития болезни Паркинсона. Неврологический журнал. 2017;22(6):287-94.</mixed-citation><mixed-citation xml:lang="en">Rybkina VL, Azizova TV. Risk factors for Parkinson's disease. Nevrologicheskii zhurnal. 2017;22(6):287-94. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Милюхина ИВ, Ермоленко ЕИ, Иванова АС, Суворов АН. Роль микробиоты желудочно-кишечного тракта в патогенезе болезни Паркинсона. Неврологический журнал. 2017;22(6):280-6.</mixed-citation><mixed-citation xml:lang="en">Milyukhina IV, Ermolenko EI, Ivanova AS, Suvorov AN. The role of gastrointestinal microbiota in the pathogenesis of Parkinson's disease. Nevrologicheskii zhurnal. 2017;22(6):280-6. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Lhermitte J, Kraus WM, McAlpine D. On the occurrence of abnormal deposits of iron in the brain in Parkinsonism with special reference to its localization. J Neurol Psychopathol. 1924 Nov;5(19):195–208.</mixed-citation><mixed-citation xml:lang="en">Lhermitte J, Kraus WM, McAlpine D. On the occurrence of abnormal deposits of iron in the brain in Parkinsonism with special reference to its localization. J Neurol Psychopathol. 1924 Nov;5(19):195–208.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Rutledge JN, Hilal SK, Silver AJ, et al. Study of movement disorders and brain iron by MR. AJR Am J Roentgenol. 1987 Aug;149(2): 365-79.</mixed-citation><mixed-citation xml:lang="en">Rutledge JN, Hilal SK, Silver AJ, et al. Study of movement disorders and brain iron by MR. AJR Am J Roentgenol. 1987 Aug;149(2): 365-79.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Z, Luo XG, Gao C. Utility of susceptibilityweighted imaging in Parkinson's disease and atypical Parkinsonian disorders. Transl Neurodegener. 2016 Oct 7;5:17. eCollection 2016.</mixed-citation><mixed-citation xml:lang="en">Wang Z, Luo XG, Gao C. Utility of susceptibilityweighted imaging in Parkinson's disease and atypical Parkinsonian disorders. Transl Neurodegener. 2016 Oct 7;5:17. eCollection 2016.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Haacke EM, Xu Y, Cheng YC, et al. Susceptibility weighted imaging (SWI). Magn Reson Med. 2004 Sep;52(3):612-8.</mixed-citation><mixed-citation xml:lang="en">Haacke EM, Xu Y, Cheng YC, et al. Susceptibility weighted imaging (SWI). Magn Reson Med. 2004 Sep;52(3):612-8.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Пронин ИН, Туркин АМ, Долгушин МБ и др. Тканевая контрастность, обусловленная магнитной восприимчивостью: применение в нейрорентгенологии. Медицинская визуализация. 2011;(3):75-84.</mixed-citation><mixed-citation xml:lang="en">Pronin IN, Turkin AM, Dolgushin MB, et al. Tissue contrast due to magnetic susceptibility: application in neuroradiology. Meditsinskaya vizualizatsiya. 2011;(3):75-84. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang W, Sun SG, Jiang YH, et al. Determination of brain iron content in patients with Parkinson’s disease using magnetic susceptibility imaging. Neurosci Bull. 2009 Dec;25(6): 353-60.</mixed-citation><mixed-citation xml:lang="en">Zhang W, Sun SG, Jiang YH, et al. Determination of brain iron content in patients with Parkinson’s disease using magnetic susceptibility imaging. Neurosci Bull. 2009 Dec;25(6): 353-60.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Wu SF, Zhu ZF, Kong Y, et al. Assessment of cerebral iron content in patients with Parkinson's disease by the susceptibility-weighted MRI. Eur Rev Med Pharmacol Sci. 2014; 18(18):2605-8.</mixed-citation><mixed-citation xml:lang="en">Wu SF, Zhu ZF, Kong Y, et al. Assessment of cerebral iron content in patients with Parkinson's disease by the susceptibility-weighted MRI. Eur Rev Med Pharmacol Sci. 2014; 18(18):2605-8.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang J, Zhang Y, Wang J, et al. Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: an in vivo MR study. Brain Res. 2010 May 12; 1330:124-30.</mixed-citation><mixed-citation xml:lang="en">Zhang J, Zhang Y, Wang J, et al. Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: an in vivo MR study. Brain Res. 2010 May 12; 1330:124-30.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Li DTH, Hui ES, Chan Q, et al. Quantitative susceptibility mapping as an indicator of subcortical and limbic iron abnormality in Parkinson's disease with dementia. Neuroimage Clin. 2018 Jul 27;20:365-373. doi: 10.1016/j.nicl.2018.07.028. eCollection 2018.</mixed-citation><mixed-citation xml:lang="en">Li DTH, Hui ES, Chan Q, et al. Quantitative susceptibility mapping as an indicator of subcortical and limbic iron abnormality in Parkinson's disease with dementia. Neuroimage Clin. 2018 Jul 27;20:365-373. doi: 10.1016/j.nicl.2018.07.028. eCollection 2018.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Dashtipour K, Liu M, Kani C, et al. Iron Accumulation Is Not Homogenous among Patients with Parkinson's Disease. Parkinsons Dis. 2015;2015:324843. doi: 10.1155/2015/324843. Epub 2015 Apr 5.</mixed-citation><mixed-citation xml:lang="en">Dashtipour K, Liu M, Kani C, et al. Iron Accumulation Is Not Homogenous among Patients with Parkinson's Disease. Parkinsons Dis. 2015;2015:324843. doi: 10.1155/2015/324843. Epub 2015 Apr 5.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Martin-Bastida A, Lao-Kaim NP, Loane C, et al. Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility. Eur J Neurol. 2017 Feb;24(2):357-365. doi: 10.1111/ene.13208. Epub 2016 Dec 16.</mixed-citation><mixed-citation xml:lang="en">Martin-Bastida A, Lao-Kaim NP, Loane C, et al. Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility. Eur J Neurol. 2017 Feb;24(2):357-365. doi: 10.1111/ene.13208. Epub 2016 Dec 16.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Wang JY, Zhuang QQ, Zhu LB, et al. Metaanalysis of brain iron levels of Parkinson's disease patients determined by postmortem and MRI measurements. Sci Rep. 2016 Nov 9; 6:36669. doi: 10.1038/srep36669.</mixed-citation><mixed-citation xml:lang="en">Wang JY, Zhuang QQ, Zhu LB, et al. Metaanalysis of brain iron levels of Parkinson's disease patients determined by postmortem and MRI measurements. Sci Rep. 2016 Nov 9; 6:36669. doi: 10.1038/srep36669.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Труфанов АГ. Атрофические изменения коры головного мозга при болезни Паркинсона, осложненной нарушениями ходьбы высшего уровня, возможности их прогнозирования с помощью МР-морфометрии. Лучевая диагностика и терапия. 2013;4(4): 35-41.</mixed-citation><mixed-citation xml:lang="en">Trufanov AG. Atrophic changes in the cerebral cortex in Parkinson's disease, complicated by higher-level walking disorders, the possibility of their prediction using MR-morphometry. Luchevaya diagnostika i terapiya. 2013; 4(4):35-41. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Литвиненко ИВ, Одинак ММ, Могильная ВИ. Боль и депрессия при болезни Паркинсона: новые терапевтические возможности прамипексола. Журнал неврологии и психиатрии им. С.С. Корсакова. 2008; 108(11):36-8.</mixed-citation><mixed-citation xml:lang="en">Litvinenko IV, Odinak MM, Mogil'naya VI. Pain and depression in Parkinson's disease: new therapeutic possibilities of pramipexol. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2008;108(11):36-8. (In Russ.).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
